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Twist, Myocyte enhancing factor 2
Drosophila
Muscle differentiation
MyogenesisThe gene vestigial (vg) plays a key role in indirect ﬂight muscle (IFM) development. We show here that vg is
controlled by the Notch anti-myogenic signaling pathway in myoblasts and is regulated by a novel 822 bp
enhancer during IFM differentiation. Interestingly, this muscle enhancer is activated in developing ﬁbers and
in a small number of myoblasts before the fusion of myoblasts with the developing muscle ﬁbers. Moreover,
we show that this enhancer is activated by Drosophila Myocyte enhancing factor 2 (MEF2), Scalloped (SD)
and VG but repressed by Twist, demonstrating a sensitivity to differentiation in vivo. In vitro experiments
reveal that SD can directly bind this enhancer and MEF2 can physically interact with both SD and TWI.
Cumulatively, our data reveal the interplay between different myogenic factors responsible for the expression
of an enhancer activated during muscle differentiation.© 2009 Elsevier Inc. All rights reserved.Introduction
Myogenesis is a complex process involving the proliferation and
migration of myoblasts, followed ﬁnally by their differentiationwhich
results in profound morphological and biochemical changes. Mor-
phologically, the myoblasts fuse to form multinucleated muscles.
Biochemically, differentiation is characterized by a coordinated
induction of genes encoding proteins necessary for the operating
functions of the muscle, such as myosin and sarcomeric actin, and
repression of genes involved in myoblast determination and
proliferation.
In Drosophila, the best-studied adult muscles are the thoracic
muscles, which can be divided into indirect ﬂight muscles (IFMs) and
direct ﬂight muscles (DFMs). Both types of muscle arise from cells
selected during embryogenesis as adult muscle progenitors expres-
sing high levels of Drosophila Twist protein (TWI) (Bate et al., 1991).
The Drosophila TWI protein is a basic helix–loop–helix (bHLH)
protein that plays a critical role during the speciﬁcation of the
mesoderm, the subdivision into different tissue types, and in both
embryonic and adult myogenesis (for reviews, see Baylies andA. Lalouette).
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ogenesis, TWI acts either as an activator or repressor of somatic
muscle development, depending on its main dimerization partner,
TWI or daughterless (DA) (Castanon et al., 2001). Upon differentia-
tion of the larval muscles, TWI expression is then lost in myogenic
tissues (Baylies and Bate, 1996) but persists in adult muscle
precursors (Bate et al., 1991). During larval stages, these cells
continue to express TWI as they proliferate in association with the
wing imaginal discs, and are referred to as adepithelial cells as long
as this association remains. Expression of TWI declines during
pupation as the myoblasts fuse and contribute to adult muscle
development (Bate et al., 1991; Currie and Bate, 1991). IFMs can be
further divided into two subsets: (i) the dorso-ventral muscles
(DVMs) formed de novo and (ii) dorsal longitudinal muscles (DLMs)
formed as the result of undifferentiated myoblasts migrating from
the wing imaginal discs to fuse with larval templates (Fernandes
et al., 1991). The genetic hierarchy leading to ﬂight muscle
differentiation remains largely under investigated. However, several
pro- or anti-myogenic inputs have been described. Whereas TWI and
the Notch pathway repress the differentiation process (Anant et al.,
1998), the Myocyte enhancing factor 2 (MEF2) and vestigial (vg)
genes promote differentiation (Lovato et al. 2005, Bernard et al.,
2006). As MEF2 and VG are expressed in undifferentiated cells, their
presence alone is not sufﬁcient to induce muscle differentiation. It
has been reported that their transcriptional activity depends on their
levels of expression and association with different protein partners
Fig. 1. Localization of IFMs in a 24 h APF pupa. Left: In a 24 h APF pupa, developing DLMs
are attached to the dorsal part of the thoracic cuticle. Right: in a 24 h APF MHC-LacZ
pupa, DLMs are labeled using an anti-βGal antibody.
259F. Bernard et al. / Developmental Biology 332 (2009) 258–272(Deng et al., 2009; Gunthorpe et al., 1999; Liotta et al., 2007; Soler
and Taylor, 2009).Therefore, a ﬁne regulation of pro- and anti-
myogenic inputs appears to be required in order for muscle
differentiation to occur.
The Notch pathway appears to be the main inhibitor of muscle
differentiation and Notch has been shown to interfere with ﬂight
muscle differentiation. One described mechanism is the maintenance
of twi expression in proliferating myoblasts (Anant et al., 1998).
Several pieces of evidence support the hypothesis that TWI is a
negative regulator of muscle differentiation during IFM formation
(Anant et al., 1998), such as the expression of TWI being found only in
myogenic precursors and declining at the start of IFM differentiation
(Fernandes et al., 1991). Moreover, maintained expression of TWI in
developing IFM lowers that of differentiation markers such as Myosin
heavy chain (Mhc) and Actin-88F (Act88F), leading to muscle
degeneration (Anant et al., 1998).
As a pro-myogenic factor, MEF2 has been shown to play pivotal
roles in muscle differentiation. It is the sole Drosophila member of
the MEF2 family (Lilly et al., 1994; Nguyen et al., 1994), in which all
members are characterized by the presence of both an MEF2 and
MADS-box motif enabling them to bind a conserved DNA sequence
in the control regions of muscle-speciﬁc genes (for review see Black
and Olson (1998)). In vertebrates, these factors are expressed in all
developing muscle cell types (for review see Black and Olson
(1998)). In Drosophila, analyses of combinations of Mef2 mutant
alleles show that MEF2 is required for correct IFM patterning and
differentiation (Cripps et al., 1998; Nguyen et al., 2002; Ranganaya-
kulu et al., 1995). Moreover, Lovato et al. showed that Mef2 is
controlled by the ecdysone pathway during pupation and that Mef2
overexpression in adepithelial cells is associated with early muscle
differentiation, thus demonstrating a positive role in adult muscle
differentiation (Lovato et al., 2005). These data suggest that a burst
of ecdysone during pupation could be responsible for Mef2 over-
activation and hence for adult muscle differentiation. More recently,
it has been shown that Holes in muscle (HIM) can negatively
regulate MEF2 activity during IFM development and thus negatively
regulate muscle differentiation (Soler and Taylor, 2009). Interest-
ingly, the Notch pathway activates HIM, suggesting that muscle
differentiation in myoblasts is inhibited by the Notch pathway in at
least two different ways: (i) through the maintenance of TWI
expression, and (ii) through MEF2 transcriptional activity repression
(Soler and Taylor, 2009).
Recently, it has been shown that Vestigial (VG) is responsible for
Notch signaling repression during IFM differentiation (Bernard et al.,
2006). Scalloped (SD), the Drosophila member of the Transcription
enhancer factor 1 (TEF-1) family, dimerizes with VG to form a
heterodimeric transcription factor in which SD carries the DNA-
binding domain and VG the transcription activating domain (Halder
et al., 1998; Simmonds et al., 1998; Vaudin et al., 1999). A recent study
showed that VG, SD and MEF2 can interact functionally and physically
as dimers or tripartite complexes during heart and somatic muscle
embryonic development (Deng et al., 2009). Furthermore, it has been
demonstrated that different subsets of muscles require different
complexes (either SD–MEF2, MEF2–VG or SD–VG–MEF2) in order to
differentiate (Deng et al., 2009). Interestingly,Mef2, vg and its cofactor
sd are expressed throughout IFM development in adepithelial cells,
myoblasts, developing ﬁbers and adult muscles (Bernard et al., 2003;
Cripps et al., 1998; Ng et al., 1996; Nguyen et al., 2002). vg has been
shown to be required in determining IFM identity (Bernard et al.,
2003; Sudarsan et al., 2001) and also in the differentiation of these
muscles (Bernard et al., 2006). The ﬁrst role is achieved through the
down-regulation of Cut (CT), a transcription factor involved in DFM
formation (Bernard et al., 2003). The latter role is achieved through
the regulation of the fringe gene which in turn leads to the down-
regulation of the Notch pathway in developing ﬁbers (Bernard et al.,
2006).Thus, differentiation requiresMef2 activation and VG to repress the
Notch pathway, suggesting that VG may act as a switch in muscle
differentiation. We therefore decided to analyze vg regulation during
this process. Although extensive studies have been carried out on vg
regulation during wing morphogenesis and brought new insights into
wing development (Kim et al., 1997; Kim et al., 1996; Klein and Arias,
1999; Neumann and Cohen, 1997; Prasad et al., 2003), vg regulation
during IFM differentiation remains largely uninvestigated. Sudarsan et
al. showed that vg is regulated by WG in adepithelial cells (2001),
however vg regulation during later stages of myogenesis has yet to be
investigated. Here we report that vg expression during IFM differ-
entiation is driven by an 822 bp conserved enhancer, referred to as
vestigial adult muscle enhancer vgAME. Expression of this enhancer
reveals a new population of myoblasts that are unfused but are
differentiating. We demonstrate that MEF2, SD and VG synergize to
activate the vgAME ex vivo and in vivo during IFM differentiation.
Moreover, we reveal a physical interaction between TWI and MEF2
which may be responsible for a decrease in MEF2/SD activity.
Materials and methods
Fly stocks
The following strains were used in this study: vgnull (Paumard-
Rigal et al., 1998), UAS-NI (Go et al., 1998), UAS-TCFDN (Bloomington
stock #4785), Mhc-LacZ (Hess et al., 1989), E(spl)m6-GFP (Lai et al.,
2000), UAS-Mef2 (Bour et al., 1995), UAS-twi (Baylies and Bate, 1996),
Nts1 (Shellenbarger and Mohler, 1978), sd68L (Srivastava et al., 2004),
UAS-sd (Simmonds et al., 1998), 1151-Gal4 (Anant et al., 1998), UAS-
H2B∷YFP (Bellaiche et al., 2001), UAS-Mef2[RNAi] (Dietzl et al., 2007),
UAS-NDN (Kumar and Moses, 2001), UAS-Him (Liotta et al., 2007), and
Act88F-GFP (Barthmaier and Fyrberg, 1995). Heat shocks on Nts1
pupae were performed as previously described by Anant et al. (1998).
Muscle preparation
Pupae dissection was performed as previously described in
Fernandes et al., (1991). IFM position and orientation in 20–24 h
APF pupae is schematically presented in Fig. 1.
Immunostaining and antibodies
Anti-VG, anti-TWI, anti-MEF2 and anti-EWG were generously
donated by S. Caroll, S. Roth, B. Paterson and K.White respectively, and
used at 1:200, 1:5000, 1:500 and 1:200 dilutions respectively. Rabbit
260 F. Bernard et al. / Developmental Biology 332 (2009) 258–272anti-βGAL antibody was purchased from Cappel (Durham, NC, USA)
and used at a 1:1000 dilution. Mouse anti-GFP (used at 1:200
dilution), chicken anti-GFP (1:1000 dilution) and rabbit anti-GFP
(1:1000 dilution) antibodies were purchased from Roche (Penzberg,
Germany), AvesLab (Tigard, USA) and Molecular Probes (Foster City,
USA) respectively. Mouse anti-βGAL and anti-Cut supernatants were
purchased from the Developmental Studies Hybridoma Bank (DSHB)
and used at a 1:200 dilution. Fluorescent-conjugated secondary
antibodies were purchased either from Molecular Probes or Jackson
Immunoresearch and used at a 1:200 dilution. When needed, Alexa
Fluor® 488 phalloidin (Molecular Probes) and DAPI (Sigma) were
added with the secondary antibodies at 87 μg/ml and 1 μg/ml
concentrations respectively.
Plasmid constructions and transgenesis
The vgAME sequence was ampliﬁed by PCR of genomic Drosophila
melanogaster DNA (Oligonucleotides: Fint4S, 5′-gactagtctggcaca-
cattgcccattttag-3′; Rint4X, 5′-gctctagagcgaaaagacggttctcctgcctg-3′)
and cloned into the pGEM-T easy (Promega), pCasper-hs43-LacZ
(GenBank #X81643) and pGL3 (Promega) vectors. vgAMEwas mutated
using the Quickchange®Site-directed Mutagenesis Kit (Stratagene).
The A/T A/G A/G A/T AT G/T C/T consensus sequences were mutated
into A/T A/G A/G A/T AC G/T C/T. Substituting the T for a C has been
shown to prevent SD binding (Halder and Carroll, 2001; Maeda et al.,
2002b). twi, Mef2, vg and sd coding sequences were cloned into the
heat-shock inducible pCasPeR-hsp70 expression vector (GenBank #
U59056). Mef2 coding sequence was cloned in pGEX-2TK. pGEX-2TK-
GST-sd and pGEX-2TK-GST-sd-TEA are described in Vaudin et al.
(Vaudin et al., 1999). Cloning data on pGEX-2TK-sdNter, -sdCter, -sd68L,
-sdΔ68L and twiΔ1–4 are available upon request.Fig. 2. VG expression in adepithelial cells and myoblasts is dependent on Notch. Immunostai
(C, D) with anti-VG antibodies. Developing ﬁbers were labeled using either anti-βGAL immu
during the third larval instar, VG is not expressed (B) whereas is it expressed inwild-type ani
only expressed in developing ﬁbers (D) whereas it is expressed in myoblasts and developinCell culture experiments and transfection assays
Drosophila S2 cells were maintained at 22 °C in standard Schneider
medium with fetal bovine serum (FBS 10% v/v) and antibiotics
(streptomycin 100 μg/ml and penicillin 100 U/ml). Transfection
assays were performed with Effectene reagent (QIAGEN) according to
the manufacturer's instructions. The Effectene: DNA ratio was 10:1
(μl:μg). For normalization, the Actin-LacZ plasmid was co-transfected
(a gift from M. Sanial). Cells were transfected with 1 μg of total
plasmid DNA (200 ng of pGL3 reporter vector (pGL3-vgAME or pGL3-
vgAME-SDAB), 100 ng of Actin-LacZ vector, 100 to 300 ng of each
expression vector (pCasPer-hsp70-Mef2, twi, sd or vg) adjusted to 1 μg
with empty pCasPer-hsp70 vector).
Following incubation for 24 h at 22 °C, cells were heat-shocked at
37 °C for 1 h and incubated for an additional 24 h at 22 °C. Fireﬂy
luciferase activities were assayed with the Luciferase Assay System kit
(Promega). β-Galactosidase activity was measured with ONPG assays
as previously described (Sambrook et al.). In each experiment, the
mean and standard deviation were calculated on six independent
transfection assays. Means were compared using the Student's t-test.
In vitro interaction tests
GST∷MEF2, GST∷SD and GST∷sd-TEA proteins: bacteria harboring
pGEX-2TK-GST-sd-TEA, -SD or -Mef2 plasmid were induced with IPTG
1mM. The fusion proteinwas puriﬁed using gluthatione-sepharose 4B
beads (GE Healthcare) as described by the manufacturer. MEF2 and
TWI proteins were produced with the TnT® Coupled Reticulocyte
Lysate Systems kit (Promega) according to the manufacturer's
protocol. [35S]methionine was purchased from Amersham. Interaction
tests were performed as described by Monnier et al. (1998).ning was performed on third larval instar wing imaginal discs (A, B) and 24 h APF pupae
nostaining (C) or phalloidin staining (D). In Nts animals raised at restrictive temperature
mals (A). In Nts1 pupae shifted to restrictive temperature between 0 h and 21 h APF, VG is
g ﬁbers in wild-type pupae (C). Asterisks indicate muscle ﬁbers.
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10 pmol of SD-ABu upper oligonucleotide were labeled with 32P-
γ-ATP by kination with T4 polynucleotide kinase (New England
Biolabs) and annealed with 50 pmol of SD-ABl lower oligonucleo-
tide. For competitive binding, 10 pmol of SD-ABu or mutated upper
SD-ABmu oligonucleotides were annealed to 10 pmol of SD-ABl or
mutated lower SD-ABml oligonucleotides respectively. The mutation
in SD-ABm has been reported to completely prevent SD binding
(see Plasmid Constructions and Transgenesis paragraph). Upper




GAT-3′Fig. 3. The 822 bp sequence enables expression in differentiated ﬁbers. Expression of the tran
antibodies (A, D), is detected in muscle ﬁbers (asterisks) but not in undifferentiated myoblas
in developing DLM (G, asterisks) and in developing DVM (G, arrowheads). G panel is a z-pro
in adult muscles (H). Asterisks indicate muscle ﬁbers.Electrophoretic mobility-shift assays
Electrophoretic mobility-shift assay reactions were carried out by
incubating 250 fmol of radiolabeled probe with 20 μg GST∷sd-TEA
protein extracts for 15 min (see In vitro interaction tests) in binding
buffer (Halder and Carroll, 2001). For competition assays, 12.5, 25 and
50 pmol of wild-type or mutated cold oligonucleotides were added to
the reaction mixture before addition of the radiolabeled probe.
Complexes were separated as described in Halder and Carroll (2001).
Results
vg regulation depends on Notch pathway in swarming myoblasts
It has been reported that Notch inactivation using a thermo-
sensitive allele (Nts1), as well as vgnull mutant, leads to IFMsgene vgAME-LacZ in 12 h APF (A–C) and 21 h APF (D–F) pupae, monitored by anti-βGAL
ts expressing TWI (B, E). Merge in C and F. In 21 h APF pupae, the vgAME-LacZ is activated
jection of several confocal sections of a 21 h APFMHC-LacZ pupa. vgAME-LacZ is activated
262 F. Bernard et al. / Developmental Biology 332 (2009) 258–272differentiation impairment. During IFM formation, it has been shown
that in 21 h APF pupae, the Notch pathway is active in myoblasts but
inactive in developing ﬁbers (Bernard et al., 2006) whereas VG is
expressed in both undifferentiated cells (adepithelial cells andmyoblasts) and differentiating muscle ﬁbers (Bernard et al., 2003).
Interestingly, vg is a target of the Notch pathway at the dorso-ventral
(D/V) boundary of the wing disc (Couso et al., 1995; de Celis et al.,
1996). Thus we postulated whether vg could be a target of the Notch
263F. Bernard et al. / Developmental Biology 332 (2009) 258–272pathway in adepithelial cells and in swarming myoblasts. Firstly,
when Nts1 second instar larvae were raised at a restrictive tempera-
ture, VG expression was lost in adepithelial cells (Figs. 2A, B).
Secondly, when Nts1 pupae were raised at a restrictive temperature
from the white pupae stage (0 h APF, 0 h After Puparium Formation)
until the equivalent of 21 h APF (Anant et al. 1998), VG expressionwas
only seen in developing muscles, whereas it was expressed in
developing muscles and swarming myoblasts in wild-type ﬂies
(Figs. 2C, D). The presence of myoblasts was veriﬁed by anti-Cut
labeling (data not shown). Thus, the Notch pathway is required for vg
expression in undifferentiated cells but not required in differentiated
muscle ﬁbers.
A conserved 822 bp intronic sequence of vestigial enables expression in
differentiating ﬁbers
Searching for sequence conservation between closely related
species has proven effective in locating regulatory sequences. This
kind of strategy was previously used to isolate the vg boundary and
quadrant enhancers bringing new insights into wing development
(Kim et al., 1996). However, these enhancers are not responsible for vg
activation during muscle differentiation (data not shown). We
therefore decided to compare the genomic sequence of vg in
two Drosophila species: Drosophila melanogaster and Drosophila
pseudoobscura. This analysis enabled us to reveal a region of 822 bp
in the fourth intron, highly conserved between the two species and
distinct from the vgQE (Supplemental Fig. 1). We then decided to
create transgenic reporter strains with β-galactosidase expression
driven by this sequence. Monitored expression of this transgene
revealed no expression associated with the wing disc. On the contrary,
an expressionwas revealed ﬁrst in developing ﬁbers at 12 h APF before
the onset of the fusion process (Figs. 3A–C), then at 21 h APF (Figs. 3D–
F) and ﬁnally at adult stage (Fig. 3H) in all IFMs (Fig. 3G; DLMs,
asterisks; DVMs, arrowheads). Conversely, we did not see any
expression during embryonic myogenesis (data not shown) and
thus concluded that this sequence monitors LacZ expression
throughout the IFM developmental process and consequently
named it vgAdult Muscle Enhancer (vgAME). Interestingly, a fainter signal
was observed in a few myoblasts swarming around developing ﬁbers.
These cells expressed MEF2 showing them to be myogenic cells (Figs.
4A–C). The vgAME enhancer was activated in these myoblasts prior to
TWI decline and Act88F-GFP activation (Figs. 4D–F, arrowheads),
whilst some fusioning myoblasts could also be observed. They
expressed neither TWI (Figs. 4D–F, double arrowheads) nor Enhan-
cer of split region transcript m6 (E(spl)m6 (Figs. 4G–I), the latter of
which reports Notch pathway activity. It has been previously shown
that Erect wing (EWG) is expressed in swarming myoblasts before
the fusion step when TWI expression declines (DeSimone et al.,
1996). We observed that vgAME positive myoblasts all express EWG
(Figs. 4J–K). Thus, it is likely that vgAME is activated after ewg.
Together, these data show that vgAME enhancer expression begins at
the onset of muscle differentiation and could be regulated by the
integration of signals from primary muscle differentiation factors.
vgAME activation is regulated by differentiation signals
It has been shown that MEF2 is required for IFM development and
differentiation (Cripps et al., 1998; Nguyen et al., 2002; Ranganaya-Fig. 4. vgAME is expressed in some myoblasts prior to fusion. In 21 h APF vgAME-LacZ pup
transgene in muscles ﬁbers (asterisks). vgAME is activated in a few MEF2 expressing my
speciﬁcally activated in muscle ﬁbers (D). Fusioning vgAME expressing myoblasts in which
Some vgAME expressing myoblasts are negative for GFP detection, showing that these myob
whereas fusioning myoblasts do not (F). In fusioning myoblasts, the Notch pathway, mon
begun to differentiate (G–I, arrowheads). EWG is expressed in several myoblasts swarmin
EWG positive myoblasts (J–L, arrows). However, myoblasts in which the vgAME enhancer is
activated and EWG expressed (J–L, double arrowhead). Asterisks indicate muscle ﬁbers.kulu et al., 1995) and is expressed in myoblasts and developing ﬁbers
during IFM development (Figs. 5D–F). Moreover, MEF2 overexpres-
sion has been shown to induce early muscle differentiation of
adepithelial cells associated with the wing disc (Lovato et al., 2005).
Thus, since vgAME is activated in differentiating ﬁbers, we tested
whether it could be regulated by MEF2. In 1151-Gal4; UAS-Mef2,
vgAME-LacZ late third instar larvae, we observed an ectopic expression
of vgAME-LacZ in the adepithelial cells (Figs. 5A–C, asterisk) as well as
the same actin structures previously described and associated with
differentiation (Figs. 5A–C, yellow arrowheads). Conversely, over-
expression of a Mef2-RNAi construct using the 1151-Gal4 driver
resulted in decreased vgAME activation (Figs. 5G–I) compared to
wild-type (Figs. 5D–F). Interestingly, this decrease can be correlated
with MEF2 levels; the more efﬁcient Mef2-RNAi is, the stronger the
decrease in vgAME activation (Supplemental Fig. 2). Recent studies
showed that HIM down-regulatesMEF2 transcriptional activity (Liotta
et al., 2007; Soler and Taylor, 2009). When HIM is overexpressed using
the 1151-Gal4 driver, vgAME activation is lowered (Figs. 5J–L). These
results therefore show that vgAME activation is sensitive to MEF2
activity levels.
Previous studies have shown that ectopic activation of the Notch
pathway in developing ﬁbers induces TWI ectopic expression and
therefore differentiation defects and muscle degeneration (Anant
et al., 1998). On the contrary, Notch inhibition in adepithelial cells
induces early differentiation (Krejci et al., 2009).When Notch is
ectopically activated in myoblasts and muscle ﬁbers using the 1151-
Gal4 driver, a strong reduction of vgAME activation is observed (Figs.
6A–C). When repressed, vgAME is ectopically activated in some
adepithelial cells (Figs. 6D, F). Since TWI ectopic expression can be
induced by the Notch pathway and is sufﬁcient to impair IFM
development (Anant et al., 1998), we tested vgAME activation in
conditions of TWI overexpression. As expected, vgAME activation was
severely reduced (Figs. 6G–I). Finally we tested vgAME activationwhen
the Wingless pathway was inhibited. As previously described
(Sudarsan et al., 2001), IFM differentiation was impaired (Figs. 6 J–L),
whilst vgAME activation was reduced (Fig. 6K). Thus, impaired IFM
differentiation occurs alongside the loss of vgAME activation, supporting
an association between this activation and induction of muscle
differentiation. Together, these data demonstrate that the vgAME
sequence is sensitive to known differentiation signals and is therefore
useful as an efﬁcient tool in studying the genetic regulation of IFM
differentiation.
SD and VG are required for IFM differentiation and vgAME activation
Analysis of the vgAME sequence has revealed several SD putative
binding sites (WRRWATKT consensus sequence, Halder et al., 2001).
Bioinformatics analysis using the CISTER program (Frith et al., 2001)
and position weighted matrices from TRANSFAC (Wingender et al.,
2000) has also revealed several putative binding sites for TEF-1, the
mammalian ortholog of SD. Since TEF-1 and SD bind close consensus
sequences (Halder and Carroll, 2001), we could reasonably assume
that these TEF-1 putative binding sites are also good SD putative
binding sites (SD-A and SD-B, Supplemental Fig. 1). Interestingly, we
found one E-box motif (CANNTG, Sandmann et al., 2006) but no
EWG (core element AYGCGCA, Eﬁok et al., 1994) or MEF2
(YTAW4TAR, Black and Olson, 1998) binding sites. As sd is expressed
in myogenic precursors and differentiating ﬁbers (Bernard et al.,ae (A–L), anti β-GAL antibodies (B, E, H, K) reveal the expression of the vgAME-lacZ
oblasts (A–C, arrowhead). In Act88F-GFP; vgAME-LacZ pupae, the Act88F promoter is
muscular GFP invades myoblast cytoplasm can be observed (D–F, double arrowhead).
lasts have not begun to fuse (D–F, arrowhead). Individualized myoblasts express TWI
itored by E(spl)m6 expression, is not activated signifying that these myoblasts have
g around the muscle ﬁber (J). The vgAME enhancer is not activated in the majority of
activated do express EWG (J–L, arrowhead). In fusioning myoblasts, vgAME enhancer is
264 F. Bernard et al. / Developmental Biology 332 (2009) 258–2722003), we wondered whether SD might be required for vgAME
activation. Hence, we looked for vgAME activation in the genetic
background of sd68L which is a strong allele leading to late pupal
lethality (Srivastava et al., 2004). We observed a strong impairment
of IFM differentiation at 21 h APF and a signiﬁcant decrease of vgAME
activation (Figs. 7D–F) compared to wild-type control (Figs. 7A–C).
As VG is a SD cofactor and vgnull mutants show strong IFM
degeneration we next decided to test vgAME activation in the vg
mutant. In this genetic background vgAME activation was strongly
reduced (Figs. 7G–I). Previous experiments have reported a domi-
nant-negative effect of overexpressing SD, resulting in the loss of
wing tissue (Simmonds et al., 1998). One model to explain this
dominant-negative effect of SD overexpression suggests that SD
competes with a functional in vivo VG–SD heterodimer by binding to
either DNA or other essential cofactors (Halder et al., 1998;
Simmonds et al., 1998). When SD is overexpressed using the 1151-
Gal4 driver, developing IFMs degenerate and vgAME activation
becomes strongly reduced (Figs. 7J–L), showing that SD can in fact
compete in vivo for vgAME activation. Thus, SD and VG are required
for IFM differentiation and vgAME activation. Next, we decided to test
the binding capacity of SD-A and SD-B sites at the SD-TEA DNA-
binding domain using electrophoretic mobility shift assays per-
formed on oligonucleotides containing SD-A+SD-B (Fig. 8). A shift
was observed with GST∷SD-TEA (Fig. 8, lane 3). This shift was
competed with non-radiolabeled wild-type oligonucleotides (Fig. 8,
lanes 4–6) whereas mutated oligonucleotides failed to compete for
the binding of the radiolabeled probe (Fig. 8, lanes 7–9). Thus, the
SD-TEA binding domain can speciﬁcally bind SD-A and SD-B sites and
participate in vgAME activation.
SD, VG and MEF2 activate vgAME synergistically
In vivo experiments have shown that the vgAME enhancer is
dependent upon MEF2 and SD activities and is decreased by TWI
overexpression. Therefore, we tested the activation of a vgAME-
luciferase transgene by SD, MEF2 and VG (as a known partner of SD) in
S2 cells. Co-transfection with a vector expressing Mef2 signiﬁcantly
induced vgAME enhancer compared to both controls (Fig. 9A). Co-
transfectionwith vectors expressing sd andMef2 induced a signiﬁcant
vgAME activation compared to both the control and transfection of
either vector alone (Fig. 9A). These results show that vgAME is a target of
MEF2 and that vgAME is synergistically activated by SD and MEF2. We
subsequently tested whether SD, MEF2 and VG could synergize to
activate vgAME. Expression of both sd and vg in S2 cells resulted in no
signiﬁcant activation of vgAME compared to the control (Fig. 9B). Co-
transfection with sd, Mef2 and vg expressing plasmids induced a
signiﬁcantly higher response than co-transfection with plasmids
containing sd and Mef2 alone (Fig. 9B). These results show that VG
increases MEF2-SD synergy to activate muscle-speciﬁc promoters,
indicating that in vivo VG may reinforce its muscular expression via
positive feedback.
Since SD-A and SD-B putative binding sites predicted by in silico
analysis seemed relevant, we generated a mutated vgAME-luciferase
(see Supplemental Fig. 1). Either alone or with SD, MEF2 still activated
the mutated vgAME (Fig. 9D) with no apparent signiﬁcant difference
(Fig. 9D), implying that the synergistic effect of SD and MEF2 requires
SD binding to SD-A and/or SD-B sites. However, no known MEF2
consensus binding sites were found in vgAME. Nevertheless, we found
several AT rich sequences (TAW3NTA) close to MEF2 consensus sites
andwe cannot exclude the possibility that MEF2 binds to these sites to
activate vgAME. We produced transgenic ﬂies carrying a vgAME-LacZ
transgene mutated in the SD-A and SD-B sites. As in S2 cells, vgAME
activation was still observed (not shown). Due to the differences in
integration sites, activation of wild-type andmutated transgeneswere
not comparable. However, this result is coherent with results obtained
in ex vivo experiments.Since TWI had been shown to repress vgAME enhancer in vivo (Figs.
6G–I), we therefore wished to test whether TWI could repress the
vgAME enhancer in S2 cells. As previously observed, co-transfection
with sd and Mef2-expressing plasmids signiﬁcantly activated the
enhancer (Fig. 9C), an activation signiﬁcantly reduced following the
co-transfection of a twi- expressing plasmid (Fig. 9C). However,
transfection of S2 cells by a twi expressing plasmid alone did not
signiﬁcantly lower vgAME basal activation suggesting that TWI acts as a
passive repressor.
MEF2 physically interacts with SD through SD Vestigial interacting
domain
Our data show that MEF2, VG and SD interact in vivo and ex
vivo to activate the vgAME enhancer. Moreover, it has been shown
that mammalian orthologs of MEF2, VG and SD interact physically
to activate muscle genes and promote muscle differentiation
(Maeda et al., 2002a). We therefore decided to test MEF2-SD
interactions in Drosophila. GST pull-down experiments were
performed with MEF2 and either full length or deleted forms of
SD. We found that SD interacts with MEF2 (Fig. 10A). This result is
in accordance with data published very recently by Deng et al.
(2009). When the N-terminal part of SD that contains the TEA
binding domain is deleted, SD-MEF2 interaction is conserved,
whereas it is lost when the N-terminal part that contains the VG
binding domain is deleted, showing that MEF2 interacts with the C-
terminal part of SD (aa 214–440; Fig. 10A). In order to map the SD
domain that interacts with MEF2 more precisely, four deleted forms
of SD were produced (SDΔVBD, SDΔ345–371, SDΔ372–411 and SDΔC-ter)
and tested for their interactions with MEF2. SD-MEF2 interaction
was only lost when the VG binding domain was deleted (aa 220–
344; Fig. 10A) showing that SD interacts with VG and MEF2
through the same domain.
TWI physically interacts with MEF2
Our data show that TWI acts as a repressor of the vgAME in vivo.
Moreover, S2 cell assays show that vgAME repression by TWI requires
MEF2 (see above). Interestingly, a previous study in mammals
showed that M-TWI can bind MEF2C and thus repress its
transcriptional activity (Spicer et al., 1996). This suggests that TWI
could also bind MEF2 in Drosophila and thus act as a MEF2
dependant repressor of vgAME. Therefore, we tested using GST pull-
down experiments whether TWI could bind MEF2 in Drosophila.
TWI protein was retained by a GST∷MEF2 fusion protein whereas it
was not by the GST alone, showing that TWI interacts with MEF2
(Fig. 10B). Spicer et al. (1996) have already demonstrated that the
HLH domain and a short conserved C-terminal domain of M-TWI
are required for M-TWI-MEF2 interaction so we tested whether
these domains are also required in Drosophila. Thus, GST pull-down
experiments were performed with TWI proteins containing dele-
tions either in a non-conserved domain (TWIΔ1), in the bHLH
domain (TWIΔ2), of the entire C-terminal part (TWIΔ3) or in the
conserved C-terminal domain (TWIΔ4). We found that TWIΔ3
protein does not interact with MEF2 whereas all other three deleted
forms do (Fig. 10B). Thus, TWI interacts with MEF2 through its C-
terminal part. However, contrary to mammals, the deletion of the
bHLH or C-terminal domain in Drosophila is not sufﬁcient to abolish
TWI-MEF2 interaction. Nevertheless, this result suggests that, as in
mammals, TWI could directly repress MEF2 activity through a
physical interaction.
Discussion
Muscle development involves a series of events includingmyoblast
proliferation, commitment and differentiation. Each step is controlled
Fig. 5. vgAME activation is activated byMEF2. Overexpression of MEF2 using the 1151-Gal4 driver (A–C) leads to the formation of actin structures (A, C, in green; DAPI inwhite) on the
late third instar wing imaginal discs. Anti-βGAL antibodies reveal an early expression of the vgAME-LacZ (asterisk in B, merge in C). At 21 h APF, in 1151-Gal4; vgAME-LacZ; UAS-Mef2
[RNAi] DLM, MEF2 levels are lowered (G, wild-type D). vgAME activation is severely reduced (H, wild-type E, merge in F and I). When MEF2 transcriptional activity is lowered
overexpressing Him (J–L), vgAME activation is strongly reduced (K), showing that vgAME is regulated by MEF2 (merge in L). Asterisks indicate muscle ﬁbers in D–L.
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Fig. 6. MEF2 overexpression ectopically activates the vgAME enhancer. When the Notch pathway is ectopically activated in developing IFM using a UAS-NI transgene (A–C), vgAME
activation is lost (B, merge in C). On the contrary, when the Notch pathway is repressed in adepithelial cells (D–E), an ectopic activation of vgAME is observed (E, merge in F). When
TWI is ectopically expressed in developing IFM (G–I) or when the Wingless pathway is inhibited (J–L), differentiation is impaired, developing IFM degenerate (G, J) and do not
activate the vgAME (H, K, merge in I and L). Asterisks indicate muscle ﬁbers.
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Fig. 7. SD and VG are required in vivo for vgAME activation. In sd68L/Y; vgAME-LacZ pupae (D–F), vgAME activation is reduced at 21 h APF (D, merge in F) compared to wild-type control
(A). vgAME activation is also severely reduced in vgnull/vgnull 21 h APF pupae (G–I). When sd is overexpressed in myoblasts and developing ﬁbers using the 1151-Gal4 driver (J–L), a
strong reduction of vgAME activation is also observed (J, merge in L).
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Fig. 8. SD-TEA domain binds SD-A and SD-B sites. EMSA of GST∷SD-TEA binding to the
SD-AB double-stranded oligonucleotide. Competitions were performed with wild-type
or mutated oligonucleotides (see Materials and methods). A band shift is observed
when the radiolabeled oligonucleotide is incubated with GST∷SD-TEA extracts
(arrowhead). GST∷SD-TEA binding to the radiolabeled probe is competed by increasing
quantities of non-radiolabeled wild-type oligonucleotides. On the contrary, GST∷SD-
TEA binding is not competed by increasing quantities of non-radiolabeled mutated
oligonucleotides. Thus, SD-TEA speciﬁcally binds the SD-A and SD-B sequences.
268 F. Bernard et al. / Developmental Biology 332 (2009) 258–272by speciﬁc genes induced by different signaling pathways. To study
these events, several models have been developed. Among them, a
model of IFM development in Drosophila has emerged over the last
few years, making use of the ever-improving arsenal of available
genetic tools to gain new insights into adult myogenesis. In this paper,
we have investigated vg regulation during IFM differentiation since vg
has been shown to be required both early on in adepithelial cells and
myoblasts for IFM identity speciﬁcation (Bernard et al., 2003;
Sudarsan et al., 2001) and later in developing IFMs to promote their
differentiation (Bernard et al., 2006). According to these require-
ments, vg is expressed throughout IFM development in myoblasts and
differentiating ﬁbers. However, despite a simple vg expression pattern,
our results show that vg regulation during IFM development is
complex and involves at least two enhancers responding to different
signals. Interestingly, a similar situation has been described in the
wing pouchwhere two distinct CRMs (vgBE and vgQE) are required to
activate vg in a complementary manner (Kim et al., 1996). Overall,
isolation and study of speciﬁc CRMs has been shown to be a fruitful
approach to understanding spatial and temporal regulation of genes
during development.
We found that vg is under the control of the Notch pathway in
adepithelial cells and myoblasts, though independent of this pathway
in muscles. However, the mechanism by which the Notch pathway
activates vg in myoblasts remains unclear. Indeed, the only known
Notch responsive element in the vg gene (vgBE, Kim et al., 1996) is not
involved in this activation (not shown). Interestingly, it has been
previously shown that vg is under the control of the Wingless
pathway in adepithelial cells (Sudarsan et al., 2001), suggesting that
the Wingless and Notch pathways could interact to activate vg in
undifferentiated cells through an as yet unknown enhancer. We
veriﬁed that WG is still correctly expressed in our Nts conditions (not
shown). Since the vg cis-regulatory element activated during
myogenesis was unknown, we looked for and isolated a new enhancer
called vgAME, which is mainly activated in developing ﬁbers. This
expression starts at 12 h APF in muscle templates before myoblast
fusion occurs. Therefore expression in muscle ﬁbers is not due to
perdurance of the β-Galactosidase from the fusion of vgAME expressing
myoblast. However, we cannot exclude the possibility that stronger
expressions at later stages are partly due to the accumulation of both
muscle and myoblast expression.
Close examination revealed that vgAME is activated in a few
myoblasts close to the ﬁber. It had been previously shown that
myoblasts swarming around the developing ﬁbers can be partitioned
in two groups according to EWG expression. Indeed it was suggested
that myoblasts begin to express EWG just before their fusion
(DeSimone et al., 1996). All the vgAME positive myoblasts express
EWG, showing that EWG expression precedes vgAME activation.
Moreover, a few isolated vgAME positive myoblasts with no Act88F-
GFP expression can be detected, showing that vgAME activation occurs
shortly before the fusion process begins. However, no EWG binding
sites were found in vgAME, and vgAME activationwas not changed in the
ewg hypomorphic mutant background (not shown). Thus, vgAME is
unlikely to be regulated by EWG. As previously described (Bernard
et al., 2006), the Notch pathway is repressed when fusion begins and
E(spl)m6 expression is lost. Thus, TWI expressing myoblasts begin to
express EWG which leads to a decline in TWI and eventually to an
expression of vgAME. Shortly after vgAME activation, the fusion process
begins and E(spl)m6 and TWI expressions are repressed. We failed to
observe clearly unfused vgAME positive myoblasts which did not
express TWI. However, a potential vgAME+-TWI− step cannot be
excluded since its short duration would make it very difﬁcult to
observe. It remains unclear whether vgAME activation in myoblasts is
a mandatory step before fusion or not. If not, this would signify that
vgAME positive myoblasts constitute a speciﬁc population. However,
our results show that vgAME is activated by differentiation signals
(see below), hence suggesting that vgAME activation occurs shortlybefore fusion in all myoblasts. Thus, vgAME activation could either
reveal an intermediary step between the undifferentiated myoblast
stage and the developing muscle ﬁbers or show that the differentia-
tion program begins prior to myoblast fusion.
In order to further investigate these early steps of muscle
differentiation, we studied vgAME regulation, ﬁnding that vgAME is
activated when differentiation is triggered, and repressed when
differentiation is impaired. The Notch pathway has previously been
described as an anti-differentiation pathway (Anant et al., 1998).
Indeed, it is responsible for maintenance of TWI in adepithelial cells.
In the embryo, TWI acts either as an activator or repressor of somatic
muscle development, depending on its main dimerization partner,
TWI or daughterless (DA) (Castanon et al., 2001). Its expression fades
during embryonic and adult muscle differentiation (Anant et al., 1998;
Baylies and Bate, 1996). During IFM differentiation, ectopic activation
of the Notch pathway in developing ﬁbers induces ectopic expression
of TWI and hence differentiation impairment (Anant et al., 1998).
Conversely, Notch repression in adepithelial cells leads to an early
differentiation (Krejci et al., 2009). Here we show that Notch
repression is associated with vgAME ectopic activation and that ectopic
activation of the Notch pathway or ectopic expression of TWI in
adepithelial cells leads to vgAME inhibition, demonstrating vgAME
regulation by differentiation and anti-differentiation signals.
We found that vgAME activation is regulated by MEF2 during IFM
differentiation. In Drosophila, MEF2 is required for embryonic
differentiation of somatic, cardiac and visceral muscles (Bour et al.,
1995; Lilly et al., 1995). Using several Mef2 alleles, it has been shown
that different embryonic muscles require different MEF2 activity
levels in order to differentiate (Gunthorpe et al., 1999; Ranganayakulu
et al., 1995) and that MEF2 target genes are activated by different
MEF2 activity levels (Elgar et al., 2008). In adult myogenesis, analyses
of combinations ofMef2mutant alleles show that MEF2 is required for
correct IFM patterning and differentiation (Cripps et al., 1998; Nguyen
et al., 2002; Ranganayakulu et al., 1995). Moreover, Lovato et al.
(2005) showed that MEF2 overexpression in adepithelial cells induces
early differentiation. Here, we show, using UAS-Mef2[RNAi], that vgAME
Fig. 9. vgAME is cis-regulated by MEF2, SD, VG and TWI. Activation of the vgAME (A–C) and the mutated vgAME-SDAB (D) enhancers by co-transfection of sd,Mef2, vg and twi. (A) vgAME
enhancer is not activated by SD alone but is signiﬁcantly activated by MEF2 alone (p=0.0296). SD and MEF2 synergistically activate vgAME (p=0.0084). (B) VG enhances vgAME
activation by SD and MEF2 (p=0.0409). (C) SD and MEF2 signiﬁcantly activate vgAME (p=0.0015). This activation is signiﬁcantly repressed by TWI (p=0.0202). (D) as with the
vgAME enhancer, the vgAME-SDAB enhancer is signiﬁcantly activated by MEF2 (p=0.0001). Nevertheless synergic activation of the enhancer by SD and MEF2 is lost, signifying that the
SD-A and SD-B sites are required for synergistic activation of vgAME by SD and MEF2.
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overexpression in adepithelial cells is associated to vgAME ectopic
activation. Thus, vgAME activation is sensitive to MEF2 levels. It has
been recently shown that HIM negatively regulates MEF2 transcrip-
tional activity during embryonic and adult myogenesis (Liotta et al.,
2007; Soler and Taylor, 2009). When HIM is overexpressed, we
observed a strong decrease in vgAME activation, showing that vgAME
activation depends on MEF2 activity levels. Altogether, these results
strongly suggest that vgAME is a direct target of MEF2 during
differentiation.
Several studies in mammals and Drosophila have shown that MEF2
can interact with VG and SD during myogenesis (Deng et al., 2009;
Maeda et al., 2002a;Maeda et al., 2002b).We found that MEF2, SD and
VG are required in vivo for vgAME activation, suggesting that, as in the
embryo (Deng et al., 2009), these factors may interact to promote IFM
differentiation. Moreover, we have shown that SD can bind SD-A and
SD-B sites in vgAME and that SD, VG and MEF2 can synergistically
activate the vgAME in S2 cell assays. It was therefore likely that SD, VG
and MEF2 could interact to directly activate the vgAME. A recent paper
showed that SD, VG and MEF2 interact physically and are required for
differentiation of speciﬁc subsets of embryonic muscles (Deng et al.,
2009). It has been shown that SD, VG and MEF2 can form eitherdipartite or tripartite complexes and that these associations are
differentially required for development of different muscles (Deng
et al., 2009). Interestingly, Deng et al. (2009) showed that VG interacts
with SD and MEF2 through different domains, suggesting that VG
could bridge SD to MEF2. We found that MEF2 interacts with the VG
binding domain of SD, suggesting that SD cannot interact with VG and
MEF2 simultaneously. Thus VG, as suggested before, could bridge SD
to MEF2 to activate the vgAME. However, this hypothesis would render
the SD-MEF2 interaction during IFM differentiation irrelevant. Inter-
estingly, the vgAME sequence exhibits a tandem of SD binding sites.
These two sites are 16 bp apart, which is consistent with a distance
where physical interactions could occur. Thus, vgAME could be
activated by a complex consisting of two different heterodimers,
SD–MEF2 and SD–VG, stabilized by VG–MEF2 interaction and binding
different SD sites. This hypothesis would conciliate Deng et al. results
with our ex vivo and in vitro data showing a synergy between SD, VG
and MEF2.
The vgAME enhancer is repressed in the majority of myoblasts
swarming around developing ﬁbers. Moreover, the vgAME sequence
contains an E-box (binding site for bHLH proteins) and our results
show that TWI represses the vgAME in vivo. Thus, we investigated this
repression further in S2 cultured cells. In these experiments,
Fig. 10. MEF2 interacts physically with SD and TWI. (A) MEF2 was transcribed and
translated in vitro and incubated with full-length or deleted forms of GST∷SD. Material
bound to GST and GST∷SD was analyzed by western-blot using an anti-MEF2 antibody.
MEF2 is retained by GST∷SD, GST∷SDC-ter, GST∷SDΔ345–371, GST∷SDΔ372–411 and
GST∷SDΔC-ter. On the contrary, it is not retained by GST∷SDN-ter and GST∷SDΔVBD.
Thus, MEF2 interacts with the VG binding domain of SD (aa 220–344). (B) Full-length
and truncated forms of TWI were transcribed and translated in vitro with [35S]-
methionine. Materials bound to GST and GST∷MEF2 extracts were analyzed by
autoradiography after SDS-PAGE. No material is retained by the GST protein whereas
TWI, TWIΔ1 (Δ242–295), TWIΔ2 (Δ362–412) and TWUΔ4 (Δ469-C-ter) are retained
by the GST-MEF2 protein. When the C-terminal part of TWI is deleted (TWIΔ3, Δ302-
C-ter), TWI-MEF2 interaction is lost. Thus, TWI interacts with MEF2 through its
C-terminal part (301–489).
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MEF2 was co-expressed with TWI and the repression induced by TWI
was never below the basal level of activation. Moreover, vgAME
repression by TWI was not abolished by mutations in the E-box
(data not shown). Thus, TWI represses vgAME independently of the E-
box. It has been previously shown in mammals that M-TWI can
physically interact with MEF2C to inhibit its activity and that this
inhibition does not require TWI binding to DNA (Spicer et al., 1996). It
has been shown using co-immunoprecipitation assays that this
interaction requires the HLH and C-terminal conserved domains
(Spicer et al., 1996). We found that MEF2 physically interacts with the
C-terminal part of TWI in Drosophila (aa 302–489). However, deletion
of either the bHLH domain (aa 362–412) or the conserved C-terminal
domain (aa 469–489) alone is insufﬁcient in abolishing MEF2-TWI
interaction. This suggests that either MEF2 and TWI interact through a
non-conserved domain or, as in mammals, they interact through these
two domains but that the deletion of only one of them is insufﬁcient in
abolishing the interaction completely. The difference observed could
be due to the technique used (GST pull-down versus co-immunopre-
cipitation) or to a genuine difference between Drosophila andmammals. Nevertheless, our results suggest that TWI could repress
MEF2 activity through a direct interaction.
IFM differentiation requires simultaneous activation of pro-
myogenic and repression of anti-myogenic signals. It has been
previously shown that MEF2 is responsible for muscle gene activation
(for review, see Black and Olson (1998)), whereas VG is responsible
for Notch pathway repression (Bernard et al., 2006). Here we show
that MEF2 can activate vg through the vgAME enhancer, suggesting that
MEF2 is at the origin of pro-myogenic signaling activation and anti-
myogenic signaling repression. Recently, a large number of MEF2
regulated CRMs have been isolated using either ChIP-enriched in silico
targets (ChEST Junion et al., 2005) or a ChIP-on-Chip (Sandmann et al.,
2006) approach at several stages of embryogenesis. As well as
isolating already known MEF2 target genes, these two studies also
identiﬁed numerous newMEF2 target genes involved at various stages
of myogenesis. Thus, it appears that MEF2 is involved in several steps
of myogenesis, from early myogenesis to terminal differentiation.
vgAME CRM was not isolated during these studies. However, vgAME is
not activated in the embryo (data not shown) and no true MEF2
binding sites were found in vgAME. These results raise one question:
how does MEF2 activate speciﬁc genes at speciﬁc stages of develop-
ment? The majority of identiﬁed CRMs were known to bind other
transcription factors (Sandmann et al., 2006). This shows that
activating speciﬁc CRMs using a combination of factors is a common
way of expressing target genes according to speciﬁc developmental
patterns. One example is the even-skipped activation in a subset of
muscular progenitors by a speciﬁc CRM containing binding sites for
TWI, Tinman proteins and Wingless, Decapentaplegic and RTK
signaling pathways effectors (Halfon et al., 2000). Here, our results
and previously published data show that vg regulation in myoblasts
integrates the Notch and the Wingless pathways (Sudarsan et al.,
2001). Later on, a regulation switch occurs and the vgAME enhancer is
activated by a synergistic action of MEF2, VG and SD and the likely
removal of vgAME inhibition.
In this paper, we investigated vg regulation during muscle
development. We have shown that although vg is expressed
throughout the whole process, the continuity of vg expression during
the myogenic process is provided by a regulation switch involving at
least two CRMs. In myoblasts, vg is activated through a Notch
responding CRM whereas the vgAME enhancer is repressed. During
the differentiation process TWI levels decline, alleviating inhibition of
MEF2/VG/SD synergistic activities. Simultaneously, the Notch path-
way activity is repressed by fringe expression (Bernard et al., 2006)
and fusion and muscle differentiation occur. These enhancers are
required to integrate different signals to sequentially activate the vg
gene. In particular, we have shown that a new vg enhancer is activated
in certain myoblasts during early differentiation and that this
enhancer responds to SD, VG and MEF2, underlining a conservation
in myogenic processes between Drosophila and mammals. One recent
study showed that the muscle identity gene ladybird (lb), which is
expressed throughout the entire process of leg muscle development,
is responsible for activating a large panel of genes with speciﬁc
involvement at different steps of myogenesis (Junion et al., 2007). It
therefore seems likely that, similar to lb, vg expression throughout
IFM development allows the activation of the speciﬁc target genes
required at each step. Thus, a complex activation of different genes
required at each step of IFM development is achieved by the complex
and sequential activation of the vg identity gene through speciﬁc
enhancers. The ability of enhancers to integrate different signals is a
key feature, far beyond IFM development, of developmental processes
in general.
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